[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Page 76113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26151]

[[Page 76113]]



Advisory Committee on the Medical Uses of Isotopes: Call for 

AGENCY: U.S. Nuclear Regulatory Commission

ACTION: Call for nominations.


SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting for 
nominations for the Patients' Rights Advocate representative position 
on the Advisory Committee of the Medical Uses of Isotopes (ACMUI). 
Patients' Rights Advocate nominees should have professional or personal 
experience with and/or knowledge about patient advocacy. Also, 
involvement or leadership with patient advocacy organizations is 

DATES: Nominations are due on or before January 26, 2021.

ADDRESSES: Nomination Process: Submit an electronic copy of resume or 
curriculum vitae, along with a cover letter, to Ms. Kellee Jamerson, 
[email protected]. The cover letter should describe the nominee's 
current involvement with patients' rights advocacy and express the 
nominee's interest in the position. Please ensure that the resume or 
curriculum vitae includes the following information, if applicable: 
Education; certification; professional association membership and 
committee membership activities; and number of years, timeframe, and 
type of setting for patient advocacy.

Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; (301) 415-7408; [email protected].

representative provides advice to the NRC staff on patients' issues 
associated with the regulation of medical applications of byproduct 
material. This advice includes ensuring patients' rights are 
represented during the development and implementation of the NRC's 
medical-use regulations. This individual is appointed based on his or 
her professional and personal experience with and/or knowledge about 
patient advocacy, as well as involvement and/or leadership with patient 
advocacy organizations.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained from 
recommendation letters or during the selection process. Nominees should 
have the demonstrated ability to establish effective work relationships 
with peers and implement successful approaches to problem solving and 
conflict resolution. ACMUI members currently serve a four-year term and 
may be considered for reappointment to an additional term. The current 
ACMUI membership is comprised of the following professionals: (a) 
Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear 
medicine physicist; (d) therapy medical physicist; (e) radiation safety 
officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) 
patients' rights advocate; (i) Food and Drug Administration 
representative; (j) Agreement State representative; (k) healthcare 
administrator; and (l) diagnostic radiologist. For additional 
information about membership on the ACMUI, visit the ACMUI Membership 
web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote up to 160 
hours per year to ACMUI business. Members are expected to attend semi-
annual meetings in Rockville, Maryland and to participate in 
teleconferences, as needed. Members who are not Federal employees are 
compensated for their service. In addition, members are reimbursed for 
travel (including per diem in lieu of subsistence) and are reimbursed 
secretarial and correspondence expenses. Full-time Federal employees 
are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 

    Dated: November 20, 2020.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-26151 Filed 11-25-20; 8:45 am]